GENE ONLINE|News &
Opinion
Blog

Cstone Pharmaceuticals
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC
2022-03-30
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
EQRx, CStone’s Low-Cost anti-PD-L1 Inhibitor Flaunts Encouraging Data in Stage 3 NSCLC
2021-09-19
Pfizer Strengthens Immuno-Oncology Portfolio with $200 Million Investment in Chinese Startup
2020-10-03
Weekly Cover:Updates on COVID-19 in Asia
2020-04-08
Weekly in Asia|Nov-2
2019-11-27
Weekly in Asia 2019|AUG-3
2019-08-25
Weekly in Asia 2019|AUG
2019-08-10
Weekly in Asia 2019|JULY-1
2019-07-19
Weekly in Asia 20190609-0615
2019-06-21
Weekly in Asia 20190602-0608
2019-06-11
Weekly in Asia (0519-0525)
2019-05-29
Weekly in Asia(0414-0420)
2019-04-26
Weekly Top 5 in China (0317-0323)
2019-03-25
Weekly Top 5 in China (0217-0223)
2019-02-22
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top